Microalbuminuria is an early marker of renal damage and has been shown to predict future cardiovascular mortality and morbidity in patients with diabetes or hypertension, as well as in subjects in the general population. In this study, we investigated the hypothesis that the presence of microalbuminuria reflects the advancement of arterial stiffness by using a study group of 136 community residents who had no cardiovascular diseases except for hypertension and who were not taking any medications. Urinary albumin concentration was determined by the standard method and corrected by creatinine. Microalbuminuria was defined as a urinary albumin/creatinine ratio of 2.0-30.0 mg/mmol creatinine. Arterial stiffness was evaluated by pulse wave velocity (PWV) determined at three points: from the heart to the carotid artery, to the brachial artery, and to the ankle. Carotid arterial pressure was determined using a tonometric sensor. Carotid ultrasonography was performed to measure carotid intima-media thickness (IMT) and carotid arterial internal dimension. 
Introduction
Microalbuminuria is a hallmark of renal damage in patients with diabetes (1) (2) (3) (4) . Increased urinary albumin excretion has been observed not only in diabetic subjects but also in hypertensive patients (5) (6) (7) , and even in subjects in the general population (8) (9) (10) (11) . It has also been demonstrated that the appearance of microalbuminuria predicts a higher incidence of gan damages, it has been suggested that high blood pressure itself can increase glomerular ultrafiltration of albumin (14) . It has also been reported that pulse pressure was an independent predictor of urinary albumin excretion in a non-diabetic population (15, 16) . Increase in arterial stiffness is the main cause of systolic hypertension and wide pulse pressure (17, 18) . Increase in aortic stiffness also significantly changes the arterial waveform and increases central blood pressure (18, 19) .
Arterial stiffness is evaluated as pulse wave velocity (PWV) using a noninvasive procedure. Several pathological conditions, including aortic calcification (20) , as well as complications in subjects with diabetes (21) have been reported to be associated with higher PWV. Moreover, it has been reported that an increase in PWV was associated with poor prognosis in subjects with hypertension (22) , end-stage renal disease (23) , and diabetes and impaired glucose tolerance (24) . Central pulse pressure has also been shown to predict mortality in end-stage renal disease (25) . These alterations may explain the poor prognosis of subjects with microalbuminuria.
Although these findings indicate that microalbuminuria reflects the presence of advanced arterial stiffness in the central artery, this possibility has not been investigated. In the present study, to examine the hypothesis that the presence of microalbuminuria can be used as an index for advanced atherosclerosis in the general population, we evaluated the association between urinary excretion of albumin and PWV in community-dwelling subjects free from cardiovascular complications.
Methods

Subjects
The Shimanami Health Promoting Program (J-SHIPP) was started in 1999 in the Shimanami district in southern Japan (26) (27) (28) . The J-SHIPP is a longitudinal study evaluating factors related to cardiovascular disease, dementia, and death, in the general Japanese population (26) (27) (28) . The present study is a part of the J-SHIPP study that was performed in 2001 in a single community. The community had a total population of 865 residents (379 men and 486 women) in 2001. All residents aged over 50 years old were invited to participate in the program, which consisted of an interview, anthropometric measurements, blood sampling, and carotid ultrasonography. About 50% of residents aged over 50, or 349 subjects, participated in the program. Information on medical history, present conditions, and drugs was obtained by interview for each subject. Subjects with a history of stroke, transient ischemic attack (TIA), myocardial infarction, angina, congestive heart failure, peripheral vascular disease, renal disease, liver disease, or cancer were excluded. Subjects taking medications for hypertension, diabetes mellitus, or dyslipidemia were also excluded from the study. Informed consent for the procedure was obtained from each subject. One hundred and thirty six subjects completed all the procedures, including urine samples and PWV measurement. All procedures were approved by the Ethical Committee of Ehime University School of Medicine.
Urinary Excretion of Albumin
Urine samples were collected after overnight fasting and stored at 80 ºC until assay. The albumin concentration was measured by the standard method (29) and corrected by creatinine. Microalbuminuria was defined as 30.0 mg/mmol creatinine≥ urinary albumin/creatinine ratio≥ 2.0 mg/mmol creatinine (12, (30) (31) (32) . The other biochemical markers were measured with an autoanalyzer.
Measurement of Brachial Arterial Pressure and PWV
Brachial arterial systolic blood pressure (SBP), diastolic blood pressure (DBP) and PWV were measured using a volume-plethysmographic apparatus (form PWV/ABI; Colin, Co., Ltd., Komaki, Japan) (33) (34) (35) . The subject was examined in the supine position, with electrocardiogram electrodes placed on both wrists, a microphone for detecting heart sounds placed on the left edge of the sternum, and cuffs wrapped on a plethysmographic sensor that determines volume pulse waveform and an oscillometric pressure sensor that measures blood pressure. Volume waveforms for the brachium and ankle were stored for a sampling time of 10 s with automatic gain analysis and quality adjustment. Sufficient waveform data were obtained in this stored sample. In a previous study, it was reported that the mean value of the phase velocity above 2-2.5 Hz was very close to the wave front velocity (36) . The characteristic points of waveforms were determined automatically according to this phase velocity theory. The components over 5 Hz were stored using pass filters and the wave front was determined.
The time interval between the wave front of the brachial waveform and that of the ankle waveform was defined as the time interval between the brachium and ankle (∆Tba). The distance between sampling points of the brachial-ankle PWV (baPWV) was calculated automatically according to the height of the subject. The path length from the suprasternal notch to the brachium (Lb) was obtained from superficial measurements and was expressed using the following equation: Lb 0.2195 height of the patients (in cm) 2.0734. The path length from the suprasternal notch to the ankle (La) was obtained using the following equation: La (0.8129 height of the patient (in cm) 12.328). Finally, baPWV was obtained by the following equation: baPWV (La Lb)/∆Tba (33, 34) .
The time interval between the foot of the second heart sound and the dicrotic notch of the brachial waveform was defined as the time interval between the heart and brachium (∆Thb). Heart-brachial PWV was obtained using the follow-ing equation: heart-brachial PWV Lb/∆Thb. The time interval between the heart and ankle (∆Tha) was obtained using the following equation: ∆Tha ∆Thb ∆Tba. Heart-ankle PWV was calculated as La/∆Tha.
Measurement of Carotid Artery Pressure Waveform and Heart-Carotid PWV
The common carotid arterial pressure waveform was recorded noninvasively using a multi-element tonometric sensor simultaneously with brachial arterial pressure. The multi-element tonometry sensor consists of 15 sensitive microsensors within 19 mm width, and it automatically selects the most proper waveform from 15 detected pulse waveforms. The tonometry sensor for the carotid artery was fixed on the neck in a clip-on way during measurement. The arm length, angle, and hold-down pressure of the sensor head were adjusted for each subject for optimal pressure wave detection.
The carotid pressure wave was recorded by calibrating the brachial pressure wave, assuming that the mean DBP was the same at both sites. For this purpose, the mean blood pressure (MBP) on the carotid pressure wave was computed and set equal to the brachial MBP in the corresponding heart beat. The carotid pressure amplitude was then computed from the DBP and the position of MBP on the carotid pressure wave (37) . The brachial SBP and carotid SBP were averaged for a series of waves over a 10-s period.
The time interval between the foot of the second heart sound and the dicrotic notch of the carotid waveform was defined as the time interval between the heart and carotid artery (∆Thc). Heart-carotid PWV was obtained using the following equation: heart-carotid PWV Lc/∆Thc. The path length from the suprasternal notch to the carotid artery (Lc) was obtained using the following equation: Lc 0.2437 body height 18.999 (35) .
Evaluation of the Carotid Artery
The right carotid artery was evaluated with an ultrasonography SSD-900 (Aloka Co., Ltd., Tokyo, Japan) using a 7.5-MHz probe. After having the subject rest for at least 10 min in the supine position with the neck in slight hyperextension, we evaluated the optimal visualization of the right common carotid artery, carotid bulb, and extracranial internal and external carotid arteries. From anterior, lateral, and posterior approaches, the intima-media thickness (IMT) of the far wall was measured in the right common carotid artery 1 cm proximal to the bulb and averaged to obtain the mean IMT (26) (27) (28) . The peak-systolic internal dimension was obtained by continuous tracing of the intima-luminal interface of the wall of the common carotid artery in three cycles and averaged. The axial resolution of the M-mode system was 0.1 mm.
Evaluation of Risk Factors
Subjects with serum creatinine exceeding 123.8 µmol/l (1.4 mg/dl) were excluded from the analysis. Hypertension was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg. Dyslipidemia was defined as total cholesterol ≥5.7 mmol/l (220 mg/dl) and/or high-density lipoprotein (HDL)-cholesterol <1.0 mmol/l (40 mg/dl). Diabetes mellitus was defined as fasting plasma glucose ≥7.0 mmol/l (126 mg/dl). Obesity was defined as body mass index (BMI) ≥25 kg/m 2 .
Statistical Analysis
All values are expressed as the mean SD unless otherwise specified. Statistical comparisons between groups were performed by ANOVA. Stepwise regression analysis for PWV was performed with the following parameters: age, sex, BMI, heart rate, brachial SBP, DBP, pulse pressure, smoking status, carotid IMT, serum creatinine, total cholesterol, HDL-cholesterol, plasma fasting glucose and presence of microalbuminuria. All analyses were performed using software packages (JMP and Statview; SAS Institute, Cary, USA). A probability value less than 0.05 was considered statistically significant.
Results
Clinical Characteristics of Subjects with Microalbuminuria
Among the 136 subjects, 32 subjects were diagnosed as having microalbuminuria. The clinical characteristics of subjects with microalbuminuria and those without microalbuminuria are summarized in Table 1 . Subjects with microalbuminuria were significantly older and had higher blood pressure and lower HDL-cholesterol. The prevalence of hypertension was significantly higher in subjects with microalbuminuria. However, there were no significant differences in the prevalence of diabetes, dyslipidemia, and current smoking habit between subjects with and without microalbuminuria.
Carotid Atherosclerosis and Carotid Arterial Pressure
Carotid arterial morphology and carotid arterial pressure are summarized in Table 2 . Microalbuminuria was associated with significant higher carotid IMT and carotid dilatation. Carotid systolic pressure and pulse pressure were significantly higher in subjects with microalbuminuria.
Microalbuminuria and PWV
The PWV values are summarized in Table 3 . Microalbuminuria was associated with significantly higher PWVs in all sites examined. Urinary albumin excretion showed significant associations with PWV (r 0. To further evaluate whether microalbuminuria is independently associated with PWV, stepwise regression analysis was performed for mean PWV. The results showed that microalbuminuria was significantly and independently associated with PWV in addition to SBP, age, and sex (Table 4) . Furthermore, logistic analysis showed that mean PWV (β 0.247, p 0.0065) and pulse pressure (β 0.23, p 0.0088) were significant predictors for the presence of microalbuminuria. Mean pulse wave velocity was obtained by averaging three pulse wave velocities from heart to carotid, to brachial, and to ankle.
HDL, high-density lipoprotein. 
<0.0001
Discussion
In the present study, we observed a close relationship between microalbuminuria and arterial stiffness identified by an increase in PWV, suggesting that the presence of microalbuminuria reflects advanced atherosclerosis in the general population. There are several possible mechanisms linking microalbuminuria and arterial stiffness. Microalbuminuria has been thought to be a part of the cardiometabolic syndrome (4). There have been several studies demonstrating an association between microalbuminuria and endothelial damage (1, 38, 39) . On the other hand, it has also been reported that endothelial dysfunction causes arterial stiffness (40) . Atherosclerosis itself may increase albumin excretion by damaging the diffusely vascular endothelium (41) . An increase in pulsatile mechanical load induced by arterial stiffness could further damage the endothelium, which in turn could induce microalbuminuria. Although microalbuminuria was first observed in diabetic patients (1), insulin resistance also plays important roles in the pathogenesis of microalbuminuria (13, 14) . Recently, it was reported that diabetic subjects have higher PWV (35) . Insulin resistance has been associated with high arterial stiffness as well as hemodynamic alteration in the carotid artery (42). Watanabe et al. (42) showed that the HOMA index was positively correlated with arterial stiffness and negatively related to diastolic blood flow in the carotid artery.
In the present study, subjects with microalbuminuria in a general population were characterized with a high prevalence of risk factors, including hypertension and advanced age. Only two subjects in the microalbumin group were free from any cardiovascular risk factor. Urinary albumin excretion showed significant associations with blood pressure in addition to PWV, indicating that hypertension was the principal factor underlying the presence of microalbuminuria in the present population. The associations between blood pressure and microalbuminuria have been explored. Not only hypertension, but also high normal blood pressure has been significantly associated with microalbuminuria (43) . Twentyfour-hour blood pressure (44) and abnormal alteration of diurnal change in blood pressure (45) have also been shown to be associated with microalbuminuria. In the present study, we observed that microalbuminuria was significantly associated with high blood pressure not only in the brachial artery but also in the carotid artery. Systemic blood pressure is a significant determinant of arterial stiffness (17) . An influence of high blood pressure on urinary albumin excretion seems to be a reasonable pathogenic mechanism, since systemic blood pressure affects the escape of albumin from the renal glomerulus, unless a preglomerular vasoconstriction protects the glomerular filter (16) .
Wide pulse pressure is also a potent predictor of microalbuminuria in hypertensive patients free from end-organ damages (1, 15, 16) . In the present population as well, we observed that subjects with microalbuminuria had wider pulse pressure. Since attenuation of the distensibility induced by an increase in arterial stiffness is the main cause of wide pulse pressure (17) (18) (19) , the close association between microalbuminuria and increased PWV could be merely a byproduct of the wide pulse pressure. However, the finding in stepwise regression analysis that microalbuminuria was independently associated with PWV indicates that the association is not merely a reflection of the increase in pulse pressure. Moreover, we observed that SBP, but not pulse pressure, was associated with PWV. Since hypertension is one of the major causes of atherosclerosis, which in turn leads to the increase in PWV, the present findings indicate that hypertension may be the mechanism linking the arterial wall stiffness and microalbuminuria. These findings may indicate the need for blood pressure control in apparently healthy elderly subjects free from any cardiovascular complication except for microalbuminuria. Further studies will be needed to address this hypothesis.
PWV has been shown to change with several confounding conditions, including cardiovascular risk factors. In the present study, the 36 subjects in the control group were free from any cardiovascular risk factors. The mean baPWV in these 36 normal subjects was 1,466 321 cm/s and was within the reference ranges of baPWV reported in a larger Japanese population free from any cardiovascular risk factors (32) . The mean baPWV in subjects with risk factor(s) in the control group (n 68, 1,740 406 cm/s) was significant- 0.019 n.s. Microalbuminuria 0.143 0.047 Mean pulse wave velocity (PWV) was obtained by averaging three PWV from heart to carotid, to brachial, and to ankle.
Stepwise regression analysis showed four parameters, age, sex, systolic blood pressure (BP) and the presence of microalbuminuria were significantly associated with mean PWV. Parameters, which were not significant and were eliminated from the equation, were shown as "n.s." BMI, body mass index; HDL, highdensity lipoprotein; IMT, intima-media thickness.
ly different from that in normal subjects ( p 0.0003) as well as that in subjects with microalbuminuria ( p 0.027). These findings indicate that PWV increases with the development of end-organ damages in addition to risk factors.
In interpreting the present study, we need to be aware of several limitations. Since the study was cross-sectional, the present findings need to be confirmed in a longitudinal study with a larger population before reaching any definite conclusions. In the present study, diabetes mellitus was not significantly associated with the presence of microalbuminuria. Since the majority of the study population had several risk factors, including hypertension and advanced age, the high prevalence of co-morbidity could weaken the association between diabetes and microalbuminuria.
In summary, the presence of microalbuminuria indicates the presence of advanced arterial stiffness in the general population. These findings further support the usefulness of measurement of urinary albumin excretion as a noninvasive and inexpensive clinical tool for the detection of subjects at high risk for cardiovascular complications, and especially hypertension, in the community.
